Biophan Technologies, Inc. Release: Research Demonstrates Ability Of The MYO-VAD(TM) To Help Prevent Progression Of Heart Disease; Paper Presented By Mark A. Anstadt, M.D. Describes Animal Studies

ROCHESTER, N.Y.--(BUSINESS WIRE)--Sept. 12, 2006--Biophan Technologies, Inc. (OTCBB:BIPH; FWB:BTN), a developer of next-generation medical technology, announced today the results of recent animal studies that demonstrated the potential of the MYO-VAD(TM) cardiac recovery system to help prevent the progression of heart failure when used to support a diseased or failing heart.